A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

By Pam Belluck from NYT Health https://ift.tt/zyx8onM
via IFTTT
Health
Clinical Trials, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, Corporations, Suits and Litigation (Civil), Brain, your-feed-science, your-feed-healthcare
New York Times
April 4, 2024 at 05:08PM